Intron associated with myotonic dystrophy type 2 and methods of use
First Claim
Patent Images
1. An isolated polynucleotide comprising about nucleotides 17501-17701 of SEQ ID NO:
- 1 and an at risk repeat tract, and the full complements thereof.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
29 Citations
8 Claims
-
1. An isolated polynucleotide comprising about nucleotides 17501-17701 of SEQ ID NO:
- 1 and an at risk repeat tract, and the full complements thereof.
- View Dependent Claims (3, 4, 5)
-
2. An isolated polynucleotide comprising about nucleotides 17858-18062 of SEQ ID NO:
- 1 and an at risk repeat tract, and the full complements thereof.
- View Dependent Claims (6, 7, 8)
Specification